Home
Dashboard
News and Info
TechIsland News
TechIsland Members

Curated content

Startups & Scaleups
Corporates
Job board
Investors
Funding rounds
Exits
Accelerators
Universities

More organizations

Matching tool
Investment heatmap
Themes

Powered by

dealroom.co

Contact
FAQ
Privacy

Companies
AlloVir
Team
Team

AlloVir

Developing cellular immunotherapies for severe viral infections. Learn more

Launch date

2013

Employees

Market cap

€78.9m

Enterprise valuation

(€31m) (Public information from Sep 2024)

Share price

$0.79 ALVR

Lincoln Massachusetts (HQ)

https://www.allovir.com/

https://twitter.com/allo_vir https://www.linkedin.com/company/allovir

View job openings

B2B
manufacturing
health
biotechnology

hard tech
biotechnology
biotech and pharma
verified unicorns and $1b exits
post ipo $1b
immune system
from $1b exit to zebra

Authorizing premium user...